About Interlinked
Interlinked is a company based in Stockholm (Sweden) founded in 2016 by Rebecca Stjernberg Bejhed, Katarina Hedbeck, and Christopher Blacker. Interlinked offers products and services including ReLink IV, ReLink Drain, LinkUS IV, and LinkUS Drain. Interlinked operates in a competitive market with competitors including Insulet, Lyra Therapeutics, TriSalus Life Sciences, Credence MedSystems and Cellectar Biosciences, among others.
- Headquarter Stockholm, Sweden
- Founders Rebecca Stjernberg Bejhed, Katarina Hedbeck, Christopher Blacker
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Interlinked Ab
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$2.07 M (USD), Grant
Sep 01, 2020
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Interlinked
Interlinked offers a comprehensive portfolio of products and services, including ReLink IV, ReLink Drain, LinkUS IV, and LinkUS Drain.
Breakaway connector to prevent dislodgement in intravenous therapy applications.
Breakaway connector for secure nephrostomy drainage and fluid management.
US version of breakaway connector for IV therapy dislodgement prevention.
US version of breakaway connector for nephrostomy drainage security.
Funding Insights of Interlinked
Investors in Interlinked
Interlinked has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Interlinked
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Interlinked
Investment portfolio details for Interlinked
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Interlinked
Detailed financials for Interlinked
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Interlinked Comparisons
Peer comparison for Interlinked
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Interlinked
Interlinked operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insulet, Lyra Therapeutics, TriSalus Life Sciences, Credence MedSystems and Cellectar Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Wearable insulin infusion systems are developed for diabetes patients.
|
|
| Locked | Locked | Locked |
Small molecule therapeutics for ENT diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of drug delivery devices to treat cancers
|
|
| Locked | Locked | Locked |
Developer of smart devices for drug delivery
|
|
| Locked | Locked | Locked |
Phospholipid drug conjugates for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Oligonucleotide delivery systems are developed for targeted gene therapy.
|
Detailed competitors of Interlinked
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Interlinked
Complete news archive for Interlinked
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Interlinked
Interlinked was founded in 2016 and raised its 1st funding round 4 years after it was founded.
Interlinked is headquartered in Stockholm, Sweden.
Katarina Hedbeck is the current CEO of Interlinked. They have also founded this company.
Interlinked was founded in 2016 in Stockholm, Sweden, and operates within the medical device sector. A breakaway connector known as ReLink is offered for IV lines to address mechanical issues, including dislodgement and spills of infusion fluids or blood. The focus remains on enhancing safety in infusion therapy procedures across healthcare settings.
Interlinked's top competitors include Insulet, Lyra Therapeutics and Halozyme.
Interlinked offers ReLink IV, ReLink Drain, LinkUS IV, and LinkUS Drain.
Interlinked has 1 investor. Key investors include European Union.